IMMUNOGLOBIN G COMPOSITION AS A MEDICAMENT FOR THE TREATMENT OF NEONATAL ICTERA BY FETOMATERNAL INCOMPATIBILITY IN THE ABO SYSTEM
- 专利权人:
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHONOLOGIES
- 发明人:
- MAZEN ELZAABI
- 申请号：
- FR0807105
- 公开号：
- FR2939667B1
- 申请日:
- 2008.12.17
- 申请国别(地区):
- FR
- 年份:
- 2012
- 代理人:
- 摘要：
- An embodiment relates to the use of an immonuglobulin (IgG) concentrate depleted of anti-A (AcaA) and anti-B (AcaB) antibodies for producing a drug intended for treating neonatal jaundice caused by maternal-fetal incompatibility with respect to the ABO system.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEM
- USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEM
- use of anti-a and anti-b antibody-poor globulin g (igg) concentrate for the treatment of neonatal jaundice due to fetal-maternal incompatibility in the abo system
- Clottable concentrate of platelet growth factors and preparation method thereof
- coagulable concentrate of platelet growth factors and derived preparation method
